Cargando…

Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors

A focused series of substituted 4H-1,2,6-thiadiazin-4-ones was designed and synthesized to probe the anti-cancer properties of this scaffold. Insights from previous kinase inhibitor programs were used to carefully select several different substitution patterns. Compounds were tested on bladder, pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalogirou, Andreas S., East, Michael P., Laitinen, Tuomo, Torrice, Chad D., Maffuid, Kaitlyn A., Drewry, David H., Koutentis, Panayiotis A., Johnson, Gary L., Crona, Daniel J., Asquith, Christopher R. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513058/ https://www.ncbi.nlm.nih.gov/pubmed/34641454 http://dx.doi.org/10.3390/molecules26195911

Ejemplares similares

1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors
por: Asquith, Christopher R. M., et al.
Publicado: (2018)

Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform
por: Bieberich, Andrew A., et al.
Publicado: (2022)

A Qualitative Comparison of the Reactivities of 3,4,4,5-Tetrachloro-4H-1,2,6-thiadiazine and 4,5-Dichloro-1,2,3-dithiazolium Chloride
por: Kalogirou, Andreas S., et al.
Publicado: (2015)

The Reaction of 4,5-Dichloro-1,2,3-dithiazolium Chloride with Sulfimides: A New Synthesis of N-Aryl-1,2,3-dithiazolimines
por: Kalogirou, Andreas S., et al.
Publicado: (2009)

In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2
por: Haidar, Samer, et al.
Publicado: (2019)

New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
por: Asquith, Christopher R. M., et al.
Publicado: (2020)

Evaluation of PVP/Au Nanocomposite Fibers as Heterogeneous Catalysts in Indole Synthesis
por: Savva, Ioanna, et al.
Publicado: (2016)

The Photochemical Mediated Ring Contraction of 4H-1,2,6-Thiadiazines To Afford 1,2,5-Thiadiazol-3(2H)-one 1-Oxides
por: Broumidis, Emmanouil, et al.
Publicado: (2023)

Decoding the Complexity of Immune–Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy
por: Maffuid, Kaitlyn, et al.
Publicado: (2023)

The Preparation and Characterization of 5-Substituted-4-chloro-1,2,3-dithiazolium Salts and their Conversion into 4-Substituted-3-chloro-1,2,5-thiadiazoles
por: Koutentis, Panayiotis A.
Publicado: (2005)

The Conversion of 5,5′-Bi(1,2,3-dithiazolylidenes) into Isothiazolo[5,4-d]isothiazoles
por: Konstantinova, Lidia S., et al.
Publicado: (2018)

Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis
por: Dutta, Dipannita, et al.
Publicado: (2012)

Binding and structural analyses of potent inhibitors of the human Ca(2+)/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors
por: Profeta, Gerson S., et al.
Publicado: (2019)

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
por: Eduful, Benjamin J., et al.
Publicado: (2021)

Oxoisoaporphine as Potent Telomerase Inhibitor
por: Wei, Zu-Zhuang, et al.
Publicado: (2016)

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
por: Haidar, Samer, et al.
Publicado: (2017)

Synthesis of [(4-Chloro-5H-1,2,3-dithiazol-5-ylidene)amino]azines
por: Koutentis, Panayiotis A., et al.
Publicado: (2011)

Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)
por: Drewry, David H., et al.
Publicado: (2014)

Crystal Structure and Solid-State Packing of 4-Chloro-5H-1,2,3-dithiazol-5-one and 4-Chloro-5H-1,2,3-dithiazole-5-thione
por: Constantinides, Christos P., et al.
Publicado: (2021)

Nigericin is a potent inhibitor of the early stage of vaccinia virus replication
por: Myskiw, Chad, et al.
Publicado: (2010)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
por: Zięba, Agata, et al.
Publicado: (2021)

Regioselective Fluorination of 7-Oxo-1,2,4-benzotriazines Using Selectfluor
por: Mirallai, Styliana I., et al.
Publicado: (2019)

Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023)

A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA
por: Schaenzer, Adam J., et al.
Publicado: (2017)

Utility of 2-thioxo-pyrido[2,3-d]pyrimidinone in synthesis of pyridopyrimido[2,1-b][1,3,5]-thiadiazinones and pyridopyrimido[2,1-b][1,3]thiazinones as antimicrobial agents
por: Zaki, Yasser H., et al.
Publicado: (2017)

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
por: Hoisnard, Léa, et al.
Publicado: (2022)

At S126
por: CERN PhotoLab
Publicado: (1974)

At S126
por: CERN PhotoLab
Publicado: (1974)

Discovery of Triterpenoids as Reversible Inhibitors of α/β-hydrolase Domain Containing 12 (ABHD12)
por: Parkkari, Teija, et al.
Publicado: (2014)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
por: Hashimoto, Sachiko, et al.
Publicado: (2002)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
por: Nava, Maria G., et al.
Publicado: (2022)

Carrageenan Is a Potent Inhibitor of Papillomavirus Infection
por: Buck, Christopher B, et al.
Publicado: (2006)

Characterization of Potent Fusion Inhibitors of Influenza Virus
por: Rowse, Michael, et al.
Publicado: (2015)

Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009)

Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
por: Huang, Fangmin, et al.
Publicado: (2023)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
por: Ahn, Ryuhjin, et al.
Publicado: (2021)

Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma
por: Pedini, Francesca, et al.
Publicado: (2019)

In Vitro Identification and In Vivo Confirmation of Inhibitors for Sweet Potato Chlorotic Stunt Virus RNA Silencing Suppressor, a Viral RNase III
por: Wang, Linping, et al.
Publicado: (2021)

Kinase Inhibitors’ Effects on Innate Immunity in Solid Cancers
por: Peng, Chunying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_crjkqljq98avss15t877gks0lu